GlassScriptPhysician profile
Yuichiro Hayashi
NPI 1225471048
$3,450.75
in general payments reported to CMS, 2019-2025
17 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,411 · 2020: $536 · 2022: $139 · 2023: $470 · 2024: $251 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $857.91 | 2019-2025 | General - Pain Management, Intracept |
| Vertiflex, INC. | $852.76 | 2019 | |
| Abbott Laboratories | $442.56 | 2020-2025 | Proclaim, Octrode, Freestyle Libre 2 |
| Stimwave Technologies Incorporated | $393.70 | 2019-2020 | |
| Avanos Medical | $203.95 | 2020-2024 | Genvisc 850 Sodium Hyaluronate |
| Medtronic, INC. | $171.36 | 2022-2025 | Inceptiv, Intellis Adaptivestim |
| Nalu Medical, INC. | $143.18 | 2022-2024 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $114.52 | 2020-2023 | Sprint Pns System |
| Forte Bio-Pharma LLC | $87.29 | 2025 | Prolate, Nalocet, Tanlor |
| Daiichi Sankyo INC. | $37.43 | 2019 | |
| Biotronik Nro, INC. | $36.82 | 2024 | Prospera |
| Medtronic USA, INC. | $30.13 | 2019 | |
| Pfizer INC. | $23.66 | 2019 | |
| Saluda Medical Americas, INC. | $18.26 | 2023 | Evoke Scs |
| Shionogi INC | $12.92 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $12.56 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuichiro Hayashi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.